Pages that link to "Q55456962"
Jump to navigation
Jump to search
The following pages link to Biological Role and Therapeutic Potential of IDH Mutations in Cancer. (Q55456962):
Displaying 33 items.
- Genetic Abnormalities, Clonal Evolution, and Cancer Stem Cells of Brain Tumors (Q57048305) (← links)
- The big picture: exploring the metabolic cross-talk in cancer (Q57167592) (← links)
- Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition (Q57790407) (← links)
- Vascular-endothelial response to IDH1 mutant fibrosarcoma secretome and metabolite: implications on cancer microenvironment (Q61808064) (← links)
- Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism (Q64109908) (← links)
- Control of the Antitumor Immune Response by Cancer Metabolism (Q64243032) (← links)
- KDM4B: A Nail for Every Hammer? (Q64252282) (← links)
- Insight into novel RNA-binding activities via large-scale analysis of lncRNA-bound proteome and IDH1-bound transcriptome (Q64255235) (← links)
- Extracellular glutamate and IDH1R132H inhibitor promote glioma growth by boosting redox potential (Q89534126) (← links)
- Long non-coding RNA LINC00467 drives hepatocellular carcinoma progression via inhibiting NR4A3 (Q89995774) (← links)
- Friend or foe-IDH1 mutations in glioma 10 years on (Q90025515) (← links)
- IDH2 reprograms mitochondrial dynamics in cancer through a HIF-1α-regulated pseudohypoxic state (Q90145023) (← links)
- Wild-Type IDH Enzymes as Actionable Targets for Cancer Therapy (Q90208059) (← links)
- Quercetin Might Promote Autophagy in a Middle Cerebral Artery Occlusion-Mediated Ischemia Model: Comments on Fawad-Ali Shah et al (Q90265012) (← links)
- Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia (Q90433123) (← links)
- Identification of Circulating Genomic and Metabolic Biomarkers in Intrahepatic Cholangiocarcinoma (Q91643878) (← links)
- Metabolic Plasticity and Epithelial-Mesenchymal Transition (Q91656884) (← links)
- Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets (Q91736543) (← links)
- Transcriptomic Analysis of Glioma Based on IDH Status Identifies ACAA2 as a Prognostic Factor in Lower Grade Glioma (Q91843726) (← links)
- Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia (Q91996647) (← links)
- Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches (Q92005700) (← links)
- Molecular pathology of tumors of the central nervous system (Q92264924) (← links)
- Metabolic Reprogramming and Vulnerabilities in Cancer (Q92443481) (← links)
- IDH1R132H Causes Resistance to HDAC Inhibitors by Increasing NANOG in Glioblastoma Cells (Q92446746) (← links)
- IDH1 fine-tunes cap-dependent translation initiation (Q92591003) (← links)
- 2-hydroxyglutarate inhibits MyoD-mediated differentiation by preventing H3K9 demethylation (Q92641569) (← links)
- IDH1-R132H mutation radiosensitizes U87MG glioma cells via epigenetic downregulation of TIGAR (Q92835299) (← links)
- Integrating Genomic Data with Transcriptomic Data for Improved Survival Prediction for Adult Diffuse Glioma (Q93198685) (← links)
- Anion-exchange chromatography mass spectrometry provides extensive coverage of primary metabolic pathways revealing altered metabolism in IDH1 mutant cells (Q95319536) (← links)
- Therapy of Primary Liver Cancer (Q99352179) (← links)
- Targeting the epigenetic regulation of antitumour immunity (Q99418746) (← links)
- NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications (Q100490619) (← links)
- Mir142 loss unlocks IDH2R140-dependent leukemogenesis through antagonistic regulation of HOX genes (Q101564396) (← links)